PKN2, a member of the protein kinase N (PKN) family, has been suggested by in vitro culture cell experiments to bind to Rho/Rac GTPases and contributes to cell-cell contact and cell migration. To unravel the in vivo physiological function of PKN2, we targeted the PKN2 gene. Constitutive disruption of the mouse PKN2 gene resulted in growth retardation and lethality before embryonic day (E) 10.5. PKN2
Introduction
Protein kinase N (PKN) is a serine/threonine protein kinase with a catalytic domain homologous to protein kinase C and a unique regulatory region containing antiparallel coiled-coil (ACC) domains (Maesaki et al. 1999; Mukai 2003) . PKN is composed of three isoforms (PKN1, PKN2 and PKN3) derived from different genes in mammals. These isoforms are ubiquitously expressed in mammalian tissues, albeit at differing amounts (Mukai 2003; Mukai et al. 2016) . PKN isoforms have been regarded as effectors of Rho family GTPases, and PKN2 (also known as PRK2/PKNc) is reported to bind to RhoA, RhoB, RhoC and Rac (Quilliam et al. 1996; Vincent & Settleman 1997; Hutchinson et al. 2013) in mammalian tissues. So far, there have been accumulating reports about the functions of PKN2, derived using mammalian cell culture experiments: PKN2 has been suggested to play critical roles in actin stress fiber formation in NIH 3T3 cells (Vincent & Settleman 1997) , keratinocyte cell-cell adhesion under the control of Rho family GTPase (Calautti et al. 2002; Bourguignon et al. 2004) , promotion of apical junction maturation of bronchial cells (Wallace et al. 2011) , neoplastic responses such as migration in 5637 bladder tumor cells (Lachmann et al. 2011 ) and prostate adenocarcinoma PC-3 cells (O'Sullivan et al. 2015) , hyaluronan-induced migration of astrocytes (Bourguignon et al. 2007 ) and control of cell cycle (G2/M transition and exit from cytokinesis) in Hela S3 cells (Schmidt et al. 2007) . To understand the in vivo physiological function of PKN2 using an organismal model, we targeted the PKN2 gene and generated PKN2
À/À mice. Both PKN1 knockout (KO) mice (Yasui et al. 2012) and PKN3 KO mice (Mukai et al. 2016) grow to adulthood without apparent external abnormalities; however, PKN2 À/À embryos unexpectedly died by embryonic day (E) 10.5 of gestation. We discuss these phenotypes with respect to the essential function of PKN2 in the growth of mouse fibroblasts.
Results
Targeting of the mouse PKN2 gene PKN2 is expressed in almost every tissue of the adult mouse and is particularly enriched in the lung, intestine and testes (Mukai et al. 2016 ). An online database also shows ubiquitous expression of PKN2 mRNAs in E14.5 mouse embryos (emage, http:// www.emouseatlas.org/emage/home.php). To investigate the in vivo physiological function of PKN2, we generated PKN2-deficient mouse line. We first constructed a targeting vector in which exons 18 and 19, encoding the area around the activation loop of the catalytic domain of PKN2, are flanked by two loxP sequences in the same orientation (Fig. 1A) . The vector was introduced into C57BL/6 ES cells by electroporation, and chimeric mice were generated from the recombinant ES clone. The PKN2 flox mouse line was established after removing the neomycin-resistant gene (neo) by crossing to a transgenic strain expressing the FLP1 recombinase gene (Fig. 1A-C) . PKN2 flox/flox mice developed to fertile adults indistinguishable from those of their wild-type (PKN2 +/+ , WT) counterparts. Expression levels of PKN2 in PKN2 flox/flox mice in various organs were comparable to those in WT mice. Expression levels of PKN2 in WT and PKN2 flox/flox mouse embryonic fibroblasts (MEFs) were shown in Fig. 3C .
PKN2
À/À mice are embryonic lethal
Next, we generated PKN2 +/À mice by crossing heterozygous PKN2 flox/+ animals with EIIa-Cre mice that express Cre recombinase under the control of the adenovirus EIIa promoter. The EIIa promoter induces expression in early mouse embryo tissues including the germ cells that transmit the genetic recombination to the progeny. The resulting heterozygous PKN2 +/À mice developed to fertile adults indistinguishable from WT mice and were intercrossed to generate PKN2 À/À mice (Fig. 1D ).
No viable PKN2 À/À embryos were found beyond E9.5, and instead, 29% of embryos were discernible as resorbed at E10.5 (Table 1) . Embryos at E8.5 and earlier stages displayed genotype distributions almost corresponding to the expected Mendelian ratios (Table 1) . No PKN2 protein or truncated fragments were detected in PKN2 À/À E8.5 embryos, whereas PKN2 +/À embryos expressed half as much PKN2 as WT mice. PKN2 À/À embryos could develop at most until the 10-somite stage but did not undergo axial turning ( Fig. 2A) . PKN2 À/À embryos were smaller than their littermates at later stages from E8.5; however, attachment of relatively large allantoises was observed (Fig. 2C) . The heart was discernible, and a heartbeat was observed in PKN2 À/À embryos. Blood cells were found in the vessels of PKN2 À/À embryos at E8.5-E9.5; however, substantial blood flow was not grossly evident ( Table 2 ). The optic vesicles and the otic vesicles were discernible in WT embryos; however, they were invisible in PKN2 À/À mice (Fig. 2B ). Neural tube closure was delayed in PKN2 À/À mice, and the cephalic region with the region overlying the forebrain-midbrain junction, which is fused first in WT mice, remained open in PKN2 À/À mice even at E9.5 (Fig. 2C ).
PKN2 is required for gastrulation
Mild growth retardation of PKN2-deficient embryos was already observed at E8.5; thus, we examined the expression pattern of the mesodermal marker Brachyury for the progress of gastrulation and germ-layer differentiation. Immunoblotting of WT embryos with anti-Brachyury antibody displayed intense expression at this stage; however, immunoblotting of PKN2 À/À embryos showed significantly weaker expression (Fig. 2D ) resembling the expression of Brachyury at the onset of gastrulation of E6.5 embryos (Wilkinson et al. 1990; Rivera-Perez & Magnuson 2005) . This result suggests that PKN2 KO induces retardation of mesoderm development during gastrulation.
PKN2 is essential for proliferation of MEFs
MEFs were obtained from E9.5 PKN2 À/À embryos, and the cell proliferation activity was measured.
PKN2
À/À MEFs were almost unable to divide whereas WT MEFs derived from littermates grew normally (Fig. 3A, B shows a partial map of the PKN2 locus before ('wt') and after ('mt') homologous recombination with the targeting vector, and after deletion of the frt-Neo-frt cassette ('flox') and after further deletion of the floxed cassette ('ko'). Positions of the frt sites and loxP sites are designated by white and black triangles, respectively. The exons, deduced by comparison with the cDNA sequence, are denoted by black boxes. Indicated genomic DNA probes (a, b) were used in Southern blotting. N2-neoR, N2-ex19 and loxP-F1 primers were used for discrimination among wt, flox lacking Neo cassette, and ko. a, probe a; b, probe b; Cre, P1 bacteriophage cyclization recombination; DT-A, Diphtheria toxin A; E, exon; FLPe, flippase; frt, FLP recombinase target; HR, homologous recombination; loxP, locus of X-over in P1; MC1 pro, MC1 promoter; Neo r , neomycin resistance gene. (B, C) Southern blot analysis. Shown is the result of representative littermates (F2 mice) obtained by crossing a pair of F1 mice, as described in Experimental procedures. It was performed using genomic DNA of F2 mice digested with AflII and ApaI/AflII probed with probe a (B) and probe b (C), respectively, as indicated in the Fig. 1A MEFs with an adenovirus for the expression of Cre recombinase resulted in a time-dependent deletion of the floxed PKN2 alleles and almost complete loss of the PKN2 protein at 3 days postinfection (Fig. 3C ). Compensatory elevation of PKN1 and PKN3 was not observed in the absence of PKN2 (Fig. 3C) . Expression of Cre recombinase in WT cells slightly decreased growth (Fig. 1 in Supporting Information), which is consistent with previous reports (Loonstra et al. 2001; Silver & Livingston 2001) . However, Cre-mediated ablation of PKN2 in PKN2 flox/flox MEFs resulted in remarkable reduction in proliferation relative to WT and PKN2 flox/+ MEFs treated with the adenovirus in the same manner (Fig. 3D) . Cleavage levels of caspase-3 and poly ADP ribose polymerase (PARP) were comparable between adenovirus-treated WT and PKN2 flox/flox MEFs ( Fig. 2 in Supporting Information), suggesting that the apoptotic change is not obvious in these MEFs. These results suggest that PKN2 plays important roles in the control of cell proliferation of MEFs at least in a cellautonomous fashion.
PKN2 is known to be cleaved by caspase-3 or related proteases in the early stages of apoptosis (Cryns et al. 1997; Takahashi et al. 1998) , and the resulting fragment binds to and prevents phosphorylation of Akt/PKB at Ser 473 and Thr 308 in vivo (Koh et al. 2000) . Full-length PKN2 is reported to inhibit Akt phosphorylation . As phosphorylation of Akt is necessary for its full activation, PKN2 may inhibit processes downstream of Akt signaling and abrogate its anti-apoptotic effects. In this context, PKN2 À/À is assumed to show a pro-survival effect. Thus, we examined the phosphorylation level of Akt in MEFs, which, however, was not significantly different between WT and PKN2 À/À cells (Fig. 4) . We also did not observe obvious anti-apoptotic accumulation of unnecessary cells in embryos except for the allantoises (Fig. 2) .
PKN2 is essential for cell cycle regulation in MEFs
Next, we investigated whether PKN2 is involved in cell cycle progression in primary MEFs by FACS analysis using propidium iodide and 5-bromo-2-deoxyuridine (BrdU) incorporation. Cre-mediated ablation of PKN2 in PKN2 flox/flox MEFs significantly decreased the S-phase population with consistent elevation of G1 and G2 populations compared to Cretreated WT MEFs (Fig. 5A, B) . Given that ablation of PKN2 affected the cell cycle progression in primary MEFs, we next examined how PKN2 influenced the levels of cell cycle regulatory proteins leading to the reduction in S-phase population. Immunoblotting of Cre-treated primary PKN2 flox/flox MEFs showed no clearly consistent changes in the levels of cyclin A, cyclin B, cyclin D, cyclin E and p27Kip1; however, it showed significant elevation of p21Waf-1/Cip1, a CDK inhibitor, compared to that of Cre-treated primary WT MEFs (Fig. 5C ). These results suggest that PKN2 is involved in the regulation of p21Waf-1/Cip1, potentially leading to the reduction in the S-phase population.
PKN2 is not essential for the growth of keratinocytes
The expression level of Brachyury was reduced in PKN2 À/À embryos, and the growth of PKN2
À/À
MEFs was impaired compared to the WT counterparts, suggesting that PKN2 has some important functions in the development of mesodermal tissues. Thus, we next focused on a tissue derived from another germ layer. We examined the development of epidermis derived from ectoderm and compared with the growth of skin fibroblasts. PKN2 activity was previously reported to increase with keratinocyte differentiation and to be required for establishment of keratinocyte cell-cell adhesion (Calautti et al. 2002; Bourguignon et al. 2004) . To investigate a role of PKN2 in the epidermis in vivo, we prepared skin-specific PKN2 KO mice by crossing our PKN2 flox mouse with the transgenic mouse carrying a keratinocyte (K5)-specific Cre gene (Tarutani et al. 1997) . In contrast to global PKN2 KO, K5-Cre; PKN2 Genes to Cells (2017) 22, 220-236 frequency, grew normally and displayed no overt phenotype. Surprisingly, an analysis of adult mouse skin also showed no discernible epidermal differences between K5-Cre; PKN2 flox/flox mice and WT or K5-Cre mice (Fig. 6A ), although complete deficiency of PKN2 was confirmed by immunoblotting of isolated mouse epidermal tissue (Fig. 6B ). This result suggests that PKN2 is not essential for the keratinocyte growth and development of mouse epidermis. Next, we isolated primary adult skin fibroblasts derived from mesoderm, and examined the cell growth. By contrast, primary adult skin fibroblasts from PKN2 flox/flox mice showed remarkable suppression of growth when treated with adenovirus for the expression of Cre recombinase as shown in Fig. 3 in Supporting Information.
Discussion
We have shown that PKN2 À/À embryos result in growth retardation and lethality before E10.5 (especially E6.5-E10.5). However, PKN1 KO mice (Yasui et al. 2012 ) and PKN3 KO mice (Mukai et al. 2016) do not show significant abnormalities in embryonic development. When we focused on fibroblasts, all of the primary PKN2 À/À fibroblasts prepared from PKN2 À/À embryos (Fig. 3A) , PKN2 flox/flox embryos (Fig. 3D) , and adult skin of K5-Cre; PKN2 flox/flox mice ( Fig. 3 in Supporting Information) showed remarkable growth suppression. In contrast, growth of PKN2 À/À keratinocytes was comparable to that of WT keratinocytes (Fig. 6) . PKN2 was not a dominant isoform in fibroblasts with respect to the amount of PKN enzyme, and fibroblasts expressed more amount of PKN1 (and total PKN) than ES cells (Fig. 4 in Supporting Information), suggesting that PKN1 (or total PKN) could not compensate for the growth suppression induced by deficiency of PKN2 in fibroblasts. PKN2 seems to play nonredundant roles particularly in the proliferation of fibroblasts in a cell-autonomous fashion, which is probably attributable to the embryonic lethal phenotype of PKN2 À/À mice. During preparation of this paper, Quetier et al. (2016) reported the phenotype of a PKN2 À/À mutation in mouse using 'knockout-first' embryonic stem cells from the Knockout Mouse Project (KOMP) (Skarnes et al. 2011) . Their 'knockout-first' allele contains an IRES:lacZ trapping cassette, and a floxed promoter-driven neo cassette inserted into the intron between exons 7 and 8, which encode a part of the N-terminal regulatory region of PKN2, thus disrupting gene function. However, our PKN2 À/À construct deletes exons 18 and 19 which encode the whole activation loop of the C-terminal catalytic domain essential for kinase activity of PKN2 and generates a frameshift mutation, triggering non-sense mediated decay of the deleted transcript. Qu etier et al. showed that PKN2 loss results in embryonic lethality at E10 and axial turning defect; these results are in good agreement with the observation in our study, which strongly suggests that PKN2 plays critical roles in mouse embryogenesis.
Earlier genetic studies in Drosophila melanogaster indicated a pivotal role of PKN in embryogenesis. The Drosophila Pkn protein, the single PKN ortholog encoded by the Drosophila genome, is required for the migration and adhesion of epidermal cells during a morphogenetic process called 'dorsal closure' of the embryo cuticle due to an inability of opposing epithelial sheets to migrate and fuse (Lu & Settleman Percentages relate the number of embryos that showed the indicated visible sign (on the left) at the indicated embryonic day to the total number of analyzed embryos of the genotype. E, embryonic day; n, number of mice. *Including embryos in resorption as described in Table 1. 1999). Abrogation of either RhoA (Strutt et al. 1997; Harden et al. 1999) or Rac (Harden et al. 1995; Woolner et al. 2005 ) function in Drosophila also impairs dorsal closure. It appears likely that PKN is transducing a Rho-and Rac-dependent signal in Drosophila embryogenesis, considering the in vitro molecular interaction between PKN and Rho family GTPases (Lu & Settleman 1999) . Both PKN1 KO mice (Yasui et al. 2012 ) and PKN3 KO mice (Mukai et al. 2016) grow to adulthood without apparent external abnormalities and do not match phenotypically, which was expected from the phenotype of the Drosophila PKN KO. However, PKN2 À/À mouse embryos in our study showed neural tube defects, a phenotype closely related to dorsal closure defect in Drosophila, and died by E10.5 of gestation. Thus, the mouse PKN2 isoform may have taken over major roles in embryogenesis from Drosophila PKN during evolution.
Does mammalian PKN2 also work downstream of Rho family GTPases as is suggested in Drosophila? PKN2 has been reported to bind to RhoA, RhoB, RhoC and Rac (Quilliam et al. 1996; Vincent & Settleman 1997; Hutchinson et al. 2013) in mammalian tissues. PKN2 has been showed to be activated by RhoA and Rac in vitro (Vincent & Settleman 1997; Bourguignon et al. 2004) . It has also been suggested that PKN2 works as a downstream target of RhoA in vivo based on the following evidence: (i) PKN2 shows sustained activation during induction of keratinocyte cell-cell adhesion by activated RhoA, and these positive effects of activated RhoA on cell-cell adhesion are not induced by an activated Rho mutant (RhoV14-Y42C) with defective binding to PKN2/ PKN1 (Calautti et al. 2002) ; (ii) siRNA-induced PKN2 knockdown resulted in defective apical junction formation of human bronchial epithelial cells; however, a RhoA-binding mutant of PKN2 (A66K, A155K) cannot rescue apical junction formation (Wallace et al. 2011) . Unfortunately, detailed phenotypes of RhoA-null mice have not been published so far; however, they were briefly mentioned to be 'embryonic lethal' in vivo (Pedersen & Brakebusch 2012) . In contrast, mice lacking RhoB or RhoC did not show an obvious developmental phenotype (Pedersen & Brakebusch 2012) . Thus, PKN2 might play roles downstream of RhoA essential for embryogenesis. Rac1 KO is also embryonic lethal whereas Rac2 and Rac3 KO mice are viable and fertile. At E6.5, Rac1-null embryos are already smaller than wild-type embryos, and at E8.5, embryos remain small and spherical without development of the anterior-posterior body axis (Sugihara et al. 1998; Migeotte et al. 2010) . When Rac1 was conditionally deleted just before the onset of neural tube closure in the surface ectoderm of the neural ridge, Rac1-deficient mice developed an exencephaly phenotype (Camerer et al. 2010) , suggesting that Rac1 is also involved in neural tube closure. In our study, neural tube closure was defective; however, anterior-posterior body axis formation was observed in PKN2 À/À mice. Therefore, Rac1 is probably performing an additional, PKN2-independent function in embryogenesis, even if PKN2 plays some important roles downstream of Rac1.
PKN1 and PKN2 have been suggested to bind to, and be phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) (Balendran et al. 2000a; Dong et al. 2000; Flynn et al. 2000) , which plays central roles in activating AGC subfamily members such as PKB, PKC, p70 S6K, p90RSK and SGK [reviewed in Belham et al. (1999) ]. It has been suggested that Rho binding to PKN1/2 leads to a conformational change that is permissive for PDK1 binding and that the resulting complex leads to the phosphorylation of PKN1/2 in flox/flox MEFs with adenovirus for the expression of Cre recombinase. The cells were grown for 3 days after adenovirus infection, and then plated as described in Experimental procedures to determine growth curves. Cells were then harvested by trypsinization and counted by a hemocytometer at indicated time intervals. Statistical significance was evaluated by ANOVA from time point between the 2nd day and the 6th day. ***, P < 0.001 (n = 3). Cre, P1 bacteriophage cyclization recombination. with defects such as no turning forebrain and heart core (Lawlor et al. 2002) . However, neural tube formation is maintained at E9.5 in PDK1 KO mouse embryos, whereas the PKN2 À/À mouse embryos reported here mostly show neural tube defects. Therefore, the activity of PKN2 seems not to be fully regulated by PDK1. This is also supported by the following observations: (i) Rintelen et al. suggest that dPDK1 genetically interacts with dAkt and dS6K but not dPKN in Drosophila (Rintelen et al. 2001) . (ii) Although Escherichia coli lacks a PDK1 homologue (Stempka et al. 1997 ) and recombinant PKN1 expressed in Escherichia coli has no activity, recombinant PKN2 expressed in Escherichia coli mild but significant protein kinase activity (Yoshinaga et al. 1999) . (iii) PKN2 is still partially phosphorylated in its activation loop even in PDK1 À/À ES cells indicating the existence of a PDK1-independent mechanism for the phosphorylation of PKN2, although the existence of PKN1 is completely dependent on PDK1 (Balendran et al. 2000b) . (iv) Co-expression of PDK1 with PKN2 only very mildly activates the enzyme compared to the increase in activation loop site phosphorylation (Flynn et al. 2000) . The relationship between PDK1 and PKN2 might be one of the causes of the nonredundant role for PKN2 among PKN family isoforms.
Schmidt et al. applied siRNA-mediated knockdown of PKN2 to the analysis of PKN2 function in HeLa S3 cells, and found that PKN2 is required for entry into mitosis and for exit from cytokinesis into the G1 phase of the cell cycle (Schmidt et al. 2007 ). In our study, Cre-mediated ablation of PKN2 in primary PKN2 flox/flox MEFs unexpectedly resulted in relative accumulation of MEFs in G1 and G2 phase and a significant decrease in S phase (Fig. 5A, B) . Different types of cells may vary in their requirements, and the PKN2 might be involved in the regulation of G1/S transition in primary MEFs. Although Rho GTPases are known to be critically involved in mitosis (David et al. 2012) , they have also been shown to regulate cell cycle entry and cell cycle progression, in particular, by regulating G1/S transition. RhoA induces cyclin D1 expression, leading to G1/S progression (Danen et al. 2000) . Inhibition of RhoA or Rac1 results in cell cycle arrest in fibroblasts at G1 phase (Yamamoto et al. 1993; Olson et al. 1995) . Absence of active RhoA leads to high levels of p27Kip1, a CDK inhibitor, resulting in cell cycle arrest in G1 (Mammoto et al. 2004) . The inhibition of RhoA results in the elevation of another CDK inhibitor, p21Waf-1/Cip1 (Coleman et al. 2006) , through post-translational stabilization as well as increased transcription. Although mDia was shown to play essential roles in this effect of RhoA on G1/S transition, other RhoA-dependent signaling events are also required for this response (Mammoto et al. 2004) . In this study, we observed changes in levels of some cell cycle regulators, which likely link to the failure of cell cycle (Fig. 5C ). Especially p21Waf-1/ Cip1 was significantly increased in primary PKN2 À/À MEFs (Fig. 5D ). PKN2 might be involved in such RhoA-mediated pathways of G1/S transition in primary MEFs through regulation of p21Waf-1/Cip1, resulting in a decreased cell population in S phase. In this paper, we focused on the nonredundant function of PKN2 among PKN family members.
Lachmann et al. previously examined whether PKN2 knockdown-induced suppression of the in vitro migration of the 5637 bladder tumor cells can be rescued by over-expression of PKN1 and PKN3, and showed that PKN isoforms are not simply redundant in supporting migration (Lachmann et al. 2011) . Our data further strengthen the notion that, despite their structural similarities, PKN2 has nonredundant important functions especially during mouse development. PKN isoforms have a well-conserved catalytic domain, which is highly similar to that of PKC family members. Betson and Settleman showed that a chimera transgene in which the kinase domain of Drosophila PKN is replaced with that of PKC53E, one of the Drosophila PKC isoforms, can rescue the substantial lethality of the PKN mutant, suggesting that even the kinase domain of PKC can functionally substitute for that of PKN during development of Drosophila (Betson & Settleman 2007) . Even in the case of mammals, the expression of a chimeric construct in which the catalytic domain in the carboxyl-terminal of human PKN2 is substituted with that from human PKN1 in bladder tumor cells partially rescues the effect of PKN2 knockdown in in vitro migration (Lachmann et al. 2011) . Therefore, the catalytic domain of PKNs in the carboxyl-terminal is rather Genes to Cells (2017) 22, 220-236 substitutable, and the regulatory region in the aminoterminal of PKN2 is supposed to be critical for its nonredundant function. So far, a few binding partners specific for PKN2 have been reported, especially through the characteristic linker region between the C2-like domain in the amino-terminal and the catalytic domain of PKN2 (Quilliam et al. 1996; Braverman & Quilliam 1999; Sun et al. 2000) . Also, each PKN isoform has a different binding affinity for individual Rho family GTPases through ACC domains in the regulatory region of PKNs (Quilliam et al. 1996; Vincent & Settleman 1997; Hutchinson et al. 2013) . Specific binding partners for PKN2 may play major roles in growing fibroblasts. Further analyses will be necessary to identify molecules specifically interacting with PKN2 to unravel the cellular processes that are responsible for the growth suppression of PKN2-depleted fibroblasts. PKN1 and PKN3 have been regarded as promising targets for the treatment of cancers (Leenders et al. 2004; Aleku et al. 2008; Metzger et al. 2008; Kohler et al. 2012; Jilg et al. 2014) . As PKN isoform-selective inhibition might be difficult to achieve using small molecule inhibitors because of the structural similarity among the different isoforms (Shiga et al. 2010) , we postulate inhibition of PKN2 by drugs prepared against PKN1 or PKN3. PKN2 itself has also been recently regarded as a target for the treatment of hepatitis C virus infection (Moon et al. 2016) . We should carefully think about the teratogenic potential of the application of these drugs during pregnancy because PKN2 is shown to be essential for embryonic development. At the same time, an inhibitor of PKN2 which has specific nonredundant functions in fibroblasts could be a new tool for the control of cell growth.
Experimental procedures

Generation of PKN2 mutant mice
A genomic fragment of the mouse PKN2 gene was isolated from mouse BAC library RPCI-23 (C57BL/6). The targeting vector for disruption of PKN2 contained a~8-kbp SalI-NotI DNA fragment including exons 16 and 17 of PKN2,~1.2-kbp SmaI/SacII fragment including exons 18 and 19 flanked by two loxP sequences, pgk-1 promoter-driven neomycin phosphotransferase gene (pgk-neo) flanked by two Flp recognition target (frt) sites, and a~4-kbp SwaI/XhoI DNA fragment and followed by the diphtheria toxin (DT) gene for negative selection (Fig. 1A) . We used the C57BL/6-derived ES cell line RENKA (Fukaya et al. 2006) for the gene targeting. The ES cells were cultured as described (Mishina & Sakimura 2007) . The targeting vector was linearized and electroporated into ES cells using Gene Pulser Xcell (Bio-Rad, Hercules, CA, USA). G-418 selection (175 lg/mL) was started 36-48 h after electroporation and continued for 1 week. The recombinant ES cell clones were identified by Southern blot analysis and were injected into 8-cell-stage embryos of ICR mice. The embryos were cultured to blastocysts and transferred to the uterus of pseudopregnant ICR mice. The resultant chimeric mice were mated with C57BL/6 mice, and the F1 mice were screened by Southern blot and PCR analysis to establish the mutant PKN2 F1 mouse line. The mutant F1 mice were crossed with the transgenic strain expressing a FLP1 recombinase gene under the direction of the human ACTB promoter (B6; SJL-Tg[ACTFLPe]9205Dym/J) to remove neomycin-resistant gene (neo) cassette. We then crossed the obtained PKN2 flox/+ mice with EIIa-Cre mice carrying a Cre transgene under the control of the adenovirus EIIa promoter to obtain PKN2 hetero KO (PKN2 +/À ) mice, and later isolated PKN2 +/À strain lacking Cre gene, and were backcrossed at least 10 times into the Charles River C57BL/ 6N background before phenotypic analysis. The resultant PKN2 +/À mice were born at a frequency expected for Mendelian inheritance.
Genotyping
Genomic DNA was isolated from ES cells and mouse tail snips by standard techniques and subjected to Southern blot analysis and PCR analysis for identification. Southern blot analysis was carried out using genomic DNA digested with AflII and ApaI/ AflII probed with probe a and probe b, respectively, as indicated in the Fig. 1A . Wild-type ('wt' in Fig. 1A ) and mutant ('mt' in Fig. 1A ) alleles containing Neo cassettes are indicated by the presence of a 16-kbp versus 18-kbp DNA fragment for probing with probe a, and a 7-kbp versus 9-kbp DNA fragment for probing with probe b. Genotyping of mouse tail, for discrimination of WT, mutant lacking Neo cassette ('flox' in Fig. 1A) , and PKN2 knockout lacking floxed region containing exon 18 and exon 19 ('ko' in Fig. 1A ), was carried out using the PCR primers N2-neoR (5 0 -CTGAGTCCCGTCTC ATGC-3 0 ), N2-ex19 (5 0 -CACAAGGGCTGTAGATTGGTG G-3 0 ), and loxP-F1 (5 0 -CTTCGTATAATGTATGCTATAC GAAG-3 0 ), yielding PCR products of 171 bp (wt), 350 bp (flox) and 227 bp (ko) (Fig. 1D) . Reaction conditions were as follows: 95°C for 3 min for one cycle, and 95°C for 1 min, 60°C for 1 min, 72°C for 1 min for 35 cycles and 72°C for 7 min for one cycle.
Antibodies
Anti-PKN1 antibody (P57920), anti-PKN2 antibody (P63720) and anti-Akt antibody (P67220) were purchased from BD Biosciences. Anti-PKN2 antibody (ab119936), anti-p21Waf-1/ Cip1 antibody (ab109199) and anti-p27Kip1 antibody (ab92741) were purchased from Abcam. The polyclonal antibody aC6 and aNUS against PKN1 and PKN3, respectively, were prepared as previously described (Mukai et al. 1996 (Mukai et al. , 2016 . Anti-p38 antibody (#9212), anti-phospho-p38 (Thr180/Tyr182) antibody (#4511), anti-ERK1/2 antibody (#9102), anti-phospho-ERK1/2 (Thr202/Tyr204) antibody (#9101), anti-phospho-PKN1 (Thr774)/PKN2 (Thr816) antibody (#2611), anti-cyclin B1 antibody (#4138), anti-cyclin D1 antibody (#2978), anti-phospho-Akt (Thr308) (244F9) antibody (#4056), and anti-phospho-Akt (Ser473) antibody (#9271), anti-cleaved caspase-3 (Asp175) (5A1E) antibody (#9664) and anti-poly ADP ribose polymerase (PARP) antibody (#9542) were purchased from Cell Signaling Technology. Anti-Brachyury antibody (sc-17743) and anti-cyclin E antibody (sc-481) were purchased from Santa Cruz Biotechnology. Anti-BrdU FITC antibody (11-5071) was purchased from eBioscience. Anti-cyclin A antibody (#644001) was purchased from BioLegend.
Animals
EIIa-Cre transgenic mice and K5-Cre transgenic mice were kindly provided by Dr Aiba (Tokyo University, Japan) and Dr Takeda (Osaka University, Japan), respectively. This study was approved by the Institutional Animal Care and Use Committee and carried out according to the Kobe University animal experimentation regulations.
Adenoviral vector
Adenoviral vector encoding Cre recombinase (AxCANCre) was kindly provided by Dr Tetsuo Noda (Shibata et al. 1997) . The high-titer adenovirus was obtained by infecting HEK293 cells and purified by ultra-centrifugation using cesium chloride (CsCl) as described previously (Luo et al. 2007 ). Then, the purified adenovirus solution was dialyzed into phosphate-buffered saline (PBS) containing 10% glycerol to remove CsCl using Slide A Lyzer TM (Thermo Fisher Scientific) and stored at À80°C before use.
Cell culture, adenoviral infection and determination of growth curves
Primary MEFs derived from E9.5 or E14.5 embryos were prepared according to standard procedures. Primary adult skin fibroblasts were prepared as described previously (Seluanov et al. 2010) . Primary fibroblasts were maintained in aMEM supplemented with 10% fetal bovine serum (FBS) (Gibco), 100 lg/mL penicillin (nacalai tesque), 100 U/mL streptomycin (nacalai tesque) in an atmosphere containing 5% CO 2 . For the expression of Cre recombinase, primary fibroblasts were infected with AxCANCre for 2 days and then allowed to recover in fresh growth medium for the indicated time. For growth curves, cells were counted using a hemocytometer and 1 9 10 5 cells were plated into 6-cm dishes. At various time points, cells were trypsinized and samples were counted using a hemocytometer. All cell culture experiments were repeated at least three times.
Immunoblot analysis
Samples were subjected to 6%-12.5% SDS-polyacrylamide gel electrophoresis (PAGE), and separated products were subsequently transferred to a polyvinylidene difluoride (PVDF) membrane. The membrane was then blocked with TBS (20 mM Tris/HCl at pH 7.5, 137 mM NaCl) containing 0.05% Tween-20 (TBS-T) and 5% normal goat serum or Blocking One (nacalai tesque) for 1 hr at room temperature. The membrane was then incubated in TBS-T and the primary antibody for 1 hr at room temperature or for overnight at 4°C. The membrane was washed three times (5 min each time) in TBS-T before incubating the blot in TBS-T containing the secondary antibody conjugated with horseradish peroxidase at 1:2000-1:10 000 dilution for 45 min. After this incubation, the membrane was subjected to three 10-min washes in TBS-T. Blots were developed by the enhanced chemiluminescence method. For immunoblotting of embryonic tissues, embryos were isolated at E8.5 from the mother animal. All extraembryonic tissue was removed before lysing the whole embryo in Laemmli sample buffer for SDS-PAGE. For immunoblotting of MEFs, the cells were once washed with PBS (-) and then lysed in Laemmli sample buffer. Protein concentrations of each sample were measured using by 660 nm Protein Assay Reagent (Pierce) according to the manufacturer's instruction. Five to hundred microgram of protein was subjected for SDS-PAGE. Intensity of each immunoreactive band was quantified by ALPHAIMAGER system (Alpha Innotech Corporation) and accompanying imaging software (FC8000).
Cell cycle analysis
MEFs were incubated with 30 lM BrdU in aMEM supplemented with 10% FBS, 100 lg/mL penicillin, and 100 U/mL streptomycin for 1 hr. The cells were fixed for at least 2 hr in ice cold 70% ethanol and DNA denatured by incubation in 2 N HCl containing 0.5% Triton X-100 for 30 min at room temperature. Samples were neutralized in 0.1 M sodium tetraborate and then washed once with PBS containing 0.5% Tween-20 and 1% BSA. The samples were incubated with a fluorescein-conjugated monoclonal antibody to BrdU at 100 lL/mL in PBS containing 0.5% Tween-20 and 1% BSA for 30 min at room temperature. Cells were washed twice in PBS containing 0.5% Tween-20 and 1% BSA, and followed by washing and staining in PBS containing propidium iodide (20 lg/mL; nacalai tesque) and RNase A (200 lg/mL; Wako). BrdU-positive nuclei were detected using two color flow cytometry for each analysis.
Hematoxylin and eosin staining of embryonic sections and mouse skin Embryos were dissected, and a tail snip or the yolk sac was removed for genotyping. Mouse embryos from littermates were fixed in 4% paraformaldehyde and embedded in paraffin Genes to Cells (2017) 22, 220-236 wax for histological analysis. Three-micrometre sections were processed after deparaffinization. The sections were incubated in hematoxylin (hematoxylin-monohydrate 0.5 g in EtOH 5 mL, aluminum potassium sulfate 12H 2 O 25.0 g, glycerin 100 mL, sodium iodate 0.9 g, distilled water 500 mL) for 10 min. After washing, the samples were incubated in acid alcohol (1% HCl in 70% EtOH) and washed again. The samples were rinsed and incubated in eosin solution (Muto pure chemicals 32042) for 2 min. Embryos were documented using an All-in-One Fluorescence Microscope BZ-9000 (Keyence). Epidermal sheets of mouse dorsal skin were prepared as described previously (Zhang et al. 2001) . Briefly, tissue samples (2 9 2 cm) of dorsal skin were scraped of excess fat and immersed in PBS/20 mM EDTA for 3 h at 37°C. The sample was placed epidermis side up on a glass slide, and an incision through the epidermis was made in one corner. Using fine forceps, the epidermis was grasped from the point of the incision and gently separated from the dermis. Biopsied skins were fixed with 10% neutralized formalin, embedded in paraffin, and then stained with hematoxylin and eosin.
Statistical analysis
Data displayed in the figures and text represent mean AE SEM of representative experiments unless otherwise stated; each experiment was repeated at least three times and involved at least triplicate measurements. Statistical significance was calculated by Student's t-test, Student's paired t-test or ANOVA. A P value <0.05 was considered significant. All data are represented as mean AE standard error.
Supporting Information
Additional Supporting Information may be found online in the supporting information tab for this article: Figure S1 Growth curves for WT primary MEFs with or without adenovirus treatment for the expression of Cre recombinase. 
